NCT01483014View on ClinicalTrials.gov

Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST)

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Gastrointestinal Stromal Tumors
Interventions
DRUG

imatinib mesylate

Trial Locations (11)

30380-490

Novartis Investigative Site, Belo Horizonte

20230-130

Novartis Investigative Site, Rio de Janeiro

88034-000

Novartis Investigative Site, Florianópolis

01401-901

Novartis Investigative Site, São Paulo

01509-900

Novartis Investigative Site, São Paulo

05403-000

Novartis Investigative Site, São Paulo

Unknown

Novartis Investivative site, Belo Horizonte

Novartis Investivative site, Florianópolis

Novartis Investivative site, Porto Alegre

Novartis Investivative site, Rio de Janeiro

Novartis Investivative site, São Paulo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY